Maxvax Biotechnology LLC
Kenmore, Washington, United States
Purpose
To develop RSV maternal vaccines to reduce RSV mortality in low and middle income countries.
Division
Global Health
Date
October 2025
Region Served
GLOBAL
Committed amount
$3,954,561
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
24
Grantee location
Kenmore, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.